CAR T-cell therapy in multiple myeloma: more room for improvement

PJ Teoh, WJ Chng - Blood Cancer Journal, 2021 - nature.com
The emergence of various novel therapies over the last decade has changed the therapeutic
landscape for multiple myeloma. While the clinical outcomes have improved significantly …

The BAFF-APRIL system in cancer

MA Ullah, F Mackay - Cancers, 2023 - mdpi.com
Simple Summary The ligands BAFF and APRIL and their cognate receptors are critical for
the differentiation, survival, and function of B cells and, as such, the maintenance of humoral …